James R. Gruber - 19 Aug 2025 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
Chief Financial Officer
Signature
/s/ James R. Gruber
Issuer symbol
ETON
Transactions as of
19 Aug 2025
Net transactions value
-$673,714
Form type
4
Filing time
20 Aug 2025, 17:14:03 UTC
Previous filing
06 Jan 2025
Next filing
12 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gruber James R. Chief Financial Officer C/O ETON PHARMACEUTICALS, INC., 21925 W. FIELD PARKWAY, SUITE 235, DEERPARK /s/ James R. Gruber 20 Aug 2025 0001923165

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock Sale $631,565 -39,082 -16% $16.16 205,299 19 Aug 2025 Direct F1, F2, F3
transaction ETON Common Stock Sale $42,149 -2,631 -1.3% $16.02 204,753 20 Aug 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $16.01 to $16.43. The price reported above reflects the weighted average sales price.
F2 The shares were sold in multiple trades at prices ranging from $15.90 to $16.19. The price reported above reflects the weighted average sales price.
F3 The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.